HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

(213)Bi-DTPA-F3

has antineoplastic activity

Also Known As:

213Bi-DTPA-F3

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organometallic Compounds: 64
  - (213)Bi-DTPA-F3: 2

Experts

1.	Blechert, Birgit: 2 articles (12/2012 - 04/2012)
2.	Bruchertseifer, Frank: 2 articles (12/2012 - 04/2012)
3.	Essler, Markus: 2 articles (12/2012 - 04/2012)
4.	Morgenstern, Alfred: 2 articles (12/2012 - 04/2012)
5.	Seidl, Christof: 2 articles (12/2012 - 04/2012)
6.	Senekowitsch-Schmidtke, Reingard: 2 articles (12/2012 - 04/2012)
7.	Aichler, Michaela: 1 article (12/2012)
8.	Baumgart, Anja: 1 article (12/2012)
9.	Feuchtinger, Annette: 1 article (12/2012)
10.	Gaertner, Florian C: 1 article (12/2012)

Related Diseases

1.	Peritoneal Neoplasms 04/01/2012 - "Therapy with both (225)Ac-DOTA-F3 and (213)Bi-DTPA-F3 increased survival of mice with peritoneal carcinomatosis. " 12/01/2012 - "Combined treatment with (213)Bi-DTPA-F3 and paclitaxel significantly increased mean survival of mice with peritoneal carcinomatosis of ovarian origin, thus favouring future therapeutic application." 12/01/2012 - "Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest."
2.	Necrosis 04/01/2012 - "Though histological analysis of kidney samples revealed acute tubular necrosis and tubular oedema in 10-30% of animals after treatment with (225)Ac-DOTA-F3 or (213)Bi-DTPA-F3, protein casts were negligible (2%), indicating only minor damage to the kidney. "

Related Drugs and Biologics

1.	Paclitaxel (Taxol)
2.	Proteins (Proteins, Gene)

Related Therapies and Procedures

1.	Therapeutics
2.	Aftercare (After-Treatment)